Furthermore, IL-1 promotes the release of growth factors and transforming growth factor-beta (TGF-β), which not only support angiogenesis but also contribute to tumor progression by modulating the tumor microenvironment and suppressing antitumor immune responses [100,101,102,103]. This evidence concerns the gene IL1A and neoplasm.